Skip to Main Content

Skip Nav Destination

Article navigation

Research Watch| February 02 2021

FLT3 Ligand Boosts Immune Response and May Enhance Anticancer Vaccines

Author & Article Information

Online ISSN: 2159-8290

Print ISSN: 2159-8274

©2021 American Association for Cancer Research.

2021

American Association for Cancer Research.

Cancer Discov (2021) 11 (2): 219.

https://doi.org/10.1158/2159-8290.CD-RW2020-171

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.